Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study.
Bartoli F., Callovini T., Cavaleri D., Crocamo C., Riboldi I., Aguglia A., De Fazio P., Martinotti G., D'Agostino A., Ostuzzi G., Barbui C., Carrà G., STAR Network Depot Investigators None.
Long-acting injectable (LAI) antipsychotics are often used for the long-term management also of bipolar disorder (BD). Nonetheless, evidence on their effect on pragmatic outcomes such as hospitalization risk in BD is inconsistent. We carried out a mirror-image study comparing rates and number of days of hospitalization, one year before and after the initiation of LAI treatment, in a sample of subjects with BD. Participants were selected from the STAR Network Depot Study, a pragmatic, observational, multicenter research involving a cohort of inpatients and outpatients consecutively started on LAI treatment. Variations in rates and in total number of days of hospitalization between the 12 months before and those after treatment initiation were analyzed. Among 461 individuals screened for eligibility, we included 71 adults with BD, initiated either on first- (FGA) or second-generation (SGA) LAIs. We found a significant decrease in terms of 12-month hospitalization rates (p